Summary:
WHAT IS KNOWN AND OBJECTIVES: Obstetrics services are a high-throughput and highrisk environment poised for pharmacist involvement, but determining how to ideally allocate services is difficult. There is recent interest in the development of tools for service prioritisation, but none are specifically targeted to obstetrics. Therefore, the aim of this study was (1) to conduct a practice audit surveying the demographics of patients attending obstetrics wards at a high-capacity maternity hospital, and (2) to evaluate a triage tool developed to prioritise pharmacy services.
METHODS:
A retrospective case review of women discharged after birth admissions was undertaken at a hospital in National Health Service (NHS) Scotland during June 2014.
Demographic and admission data were collected, as well as pharmacist interventions and missed opportunities in patient care on postnatal wards. A pharmacy triage tool was developed and retrospectively applied to each case to ascertain a risk category that would trigger and target pharmacist review. Interventions/opportunities were classified as either clinical (medication-related) or administrative (potential for error development).
RESULTS AND DISCUSSION:
175 cases were reviewed with a median age of 29 years old.
Eighty-six patients (49.1%) were retrospectively classified with elevated risk using the triage tool. A total of 117 charts (66.9%) were identified with missed opportunities for pharmacist intervention, which was significantly higher among patients classified as higher risk (75.6 vs.
58.4%, p=0.017). Compared to low risk patients, patients with a higher risk classification had lower rates of administrative missed opportunities (55.4 vs. 80.8%, p=0.015), but numerically higher rates of clinical (26.2 vs. 9.6%, p=NS) and mixed clinical/administrative (18.5 vs.
9.6%, p=NS) missed opportunities, although this failed to reach statistical significance.
WHAT IS NEW AND CONCLUSION:
Evaluation of a triage tool for obstetric services demonstrated potential for prioritising higher risk patients for pharmacist review and addressing opportunities for clinical improvements.
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Main text: WHAT IS KNOWN AND OBJECTIVE:
Pharmacists play an integral role in the hospital setting for ensuring the safe and optimal use of medications, as well as optimising medication therapy with the most efficient use of available resources. However, pharmacists themselves have become a limited resource in the face of increasing numbers of hospital admissions, changing patient demographics, and increased complexities of medication therapy regimens. In the absence of a clinical pharmacist ideally being involved in every hospital case, there is need to prioritise where services are most required.
Tools for pharmacist service prioritisation have been developed for the general hospital population. A recent effort to identify high-risk patients was trialled in National Health Service (NHS) Ayrshire & Arran health board using medication-specific 'flags' identified from the electronic prescribing system, such as use of anticoagulants, or extended durations of antibiotic utilisation. 1 Similarly, a group of pharmacists in New Zealand developed a fully integrated tool which expanded upon this concept and identified 38 clinical characteristics which contribute to calculating a priority risk score for a patient. 2 The tools rely largely on events during admission to determine potential risk, such as high-risk medications removed from automated dispensing cabinets (aka 'Pyxis machines'), transfers to higher acuity units, Due to the urgency associated with obstetrics admissions, predicting service needs and coverage is difficult; as such, triage tools have been the focus among medical, nursing and midwifery staff. 5 Development of a triage protocol for pharmacists working in obstetrics is
lacking, yet has the potential to not only aid patient care, but improve service planning.
Accordingly, the aim of this study was (1) to conduct a practice audit surveying the demographics of patients attending maternity wards at a high-capacity obstetrics facility, and (2) to evaluate a triage tool developed to prioritise pharmacy services.
METHODS:
Practice setting
The study was undertaken in an urban medical centre in Scotland with 100 beds allocated to 
Statistical analysis
Statistical analysis was performed using Minitab ® 16 (Minitab Ltd., Coventry, UK) and SPSS Statistics 21 (IBM Corporation, Armonk, NY, USA). Continuous data were compared using a
Mann-Whitney test, and categorical data were compared with a 2-proportion test with a
Bonferroni correction applied to reduce the error associated with multiple comparisons. The project was considered a service evaluation by the West of Scotland Research Ethics
Service and was exempt from ethics review.
RESULTS AND DISCUSSION:
A total of 175 patient charts were retrospectively reviewed, with demographic and admissions characteristics detailed in Table 1 . Patients had a median age of 29 years old, and largely were on their 2 nd pregnancy with a median gestation of 39 weeks and 2 days.
The slight majority of patients had planned admissions, of which 34 patients (37.0% of cases) resulted in SVD; a total of 54 patients (65.1%) with spontaneous admissions resulted in an SVD (p<0.001 for difference). Median LOS was reduced slightly (2.5 vs. 3.0 days, p<0.001) among spontaneous admissions. Less than 10% of patients delivered by assisted methods (labelled as 'other'), including forceps, ventouse or breech deliveries. Some demographic data were unavailable (<3% patients) due to lack of notation in the chart.
A total of 86 patients (49.1%) were retrospectively classified as higher risk ('red') using the triage criteria. The most common criteria for red classification was medical co-morbidity (57 patients; 66.2% of group), followed by demographics (43 patients; 50.0% of group) and high- The rate of any missed opportunities was increased 30% among 'red' patients; more importantly, the rate of clinical missed opportunities was nearly 3-fold higher. It is difficult from the nature of this study to quantify the measureable impact of pharmacist review/intervention and the eventual impact of these missed opportunities. This study did not focus on traditional 'hard' clinical outcomes such as death, but rather examined potential for optimisation of care in areas that may develop into adverse events (incorrect analgesia leading to unnecessary levels of pain, or incorrect VTE assessment leading to potential clot formation). However, a host of other literature supports the positive impact of pharmacist involvement in a variety of settings for enhanced patient satisfaction, 7-8 improvement in clinical outcomes [9] [10] [11] and reduction of errors. [12] [13] [14] Results from this study suggest that identifying and prioritising high risk (red) patients at admission using the triage tool would have potential for improvements in clinical care, as these patients made up over threequarters of clinical problems that failed to be addressed.
For example, the incidence of VTE and pulmonary embolism has been shown to be 5-fold and 15-fold higher, respectively, in the postpartum period as compared to pregnancy alone. 15 Approximately 20% of clinical interventions/missed opportunities (and 4% of patients in the study) had evidence of suboptimal LMWH dosing, duration or use. Assuming the aforementioned risk of VTE in postpartum women 14 and obstetric capacity in the hospital over a year, this would have the potential to put approximately 260 postpartum women at risk and result in approximately 1 preventable VTE event each year. Triage of high risk patients to pharmacy services has potential to prevent such events.
Our data collection stratified interventions and opportunities according to whether they were administrative, clinical or a combination of both. Administrative issues were captured based on their procedural potential to develop into errors. For instance, a lack of accurately recorded weight has been associated with a variety of errors, most commonly resulting in over-or under-dosage, and usually among high-risk medications. 16 Lack of completeness and accuracy in charting is a known issue across many medical settings, [17] [18] [19] but pharmacists can significantly improve these problems, 20 and as a part of the multi-disciplinary team, have a professional obligation to optimise these practices whenever possible. The Safer Patients
Initiative in the UK, published in 2011, identified medicines management as one of four key areas for improving reliability and safety in hospital care; among drivers promoting safe and effective processes, the use of standardised protocols, dose-guided algorithms and identification of high-risk areas were main components. 21 Therefore, the administrative issues identified in the present analysis may reveal areas poised for quality improvement and safer obstetric care.
The Standards for Maternity Care report, published by the Royal College of Obstetricians and Gynaecologists in 2008, notes the use of multi-disciplinary teams as an essential component of service delivery, particularly with regards to management of pre-existing medical conditions and intrapartum care. 22 However, the contribution of pharmacists to this goal, alongside obstetricians and other clinicians, has yet to be fully realised. 23 Shared responsibility of medication-related issues across the multi-disciplinary team enhances patient care and lessens the potential for adverse events. At current time, pharmacists at the facility contribute to the development of practice guidelines and medical/pharmacy student teaching in addition to their clinical duties. Implementation of a triage tool would open up an untapped opportunity for pharmacy service involvement and input -medication reconciliation. One study from the USA estimated that 85% of order errors among hospitalised patients originated from suboptimal medication histories. 24 Guidance from the National Centre for Health and Clinical Excellence and the National Patient Safety Agency in the UK from 2007 states that policies should be in place to ensure responsibility for an accurate medication history upon hospital admission. 25 In 2012, the American Society of Health-System Pharmacists issued a statement on pharmacist involvement in medication reconciliation, recommending that the profession assume key roles in the development and execution of the process, while recognising that it remains a multi-disciplinary approach. 25 Implementation of the triage tool could be a good opportunity for efforts in medication reconciliation to be assisted by pharmacists, who are suited to contribute based on their training and expertise.
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There are limitations associated with our work. As a retrospective quality improvement audit, the present study is restrained by its sample size and technique. However, birth statistics at the national level indicate the patient population included in this study to be well-matched with regards to mode of delivery, maternal age and gestation, 28 demonstrating the external validity of our patient cohort. There is also limitation in the capture of pharmacist interventions through the use of retrospective data collection, as recommendations made by pharmacists on the ward may be verbal (and not documented in the chart), or pre-emptive to physician orders. Therefore, the issues captured by the current study likely represent only a sample of the full spectrum of pharmacist involvement in clinical care; however, full capture would not likely be possible under any research protocol.
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WHAT IS NEW AND CONCLUSION:
Evaluation of a triage tool for obstetric services demonstrated an effective means of targeting and prioritising higher risk patients for pharmacist review. Opportunities exist for several service improvements with said tool, including formalised medication reconciliation, better coordination within the multi-disciplinary team and prevention of adverse events through enhanced safety. Our future work will test clinical implementation of the triage tool on the ward on a longitudinal basis to investigate interdisciplinary acceptance of its use, as well as clinical outcomes. There is further potential in the future to expand pharmacist involvement into the late antenatal period through clinic visits, to pre-empt risk on admission and aid in service planning.
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